RZLV logo

RZLV
Rezolve AI Limited

13,201
Mkt Cap
$1.01B
Volume
460,942.00
52W High
$8.45
52W Low
$1.07
PE Ratio
-6.77
RZLV Fundamentals
Price
$2.56
Prev Close
$2.52
Open
$2.54
50D MA
$2.63
Beta
1.42
Avg. Volume
18.78M
EPS (Annual)
-$0.3784
P/B
3.49
$736.85
Loading...
Loading...
News
all
press releases
Rezolve AI (NASDAQ:RZLV) Trading Down 3.8% - Here's Why
Rezolve AI (NASDAQ:RZLV) Stock Price Down 3.8% - Here's Why...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
Why Rezolve AI Stock Is Volatile Today
Key PointsThe company's shares initially popped by more than 16% before falling rapidly...
Nasdaq News: Markets·20h ago
News Placeholder
Rezolve AI Target of Unusually Large Options Trading (NASDAQ:RZLV)
Rezolve AI PLC (NASDAQ:RZLV - Get Free Report) saw some unusual options trading activity on Monday. Investors purchased 27,864 call options on the stock. This is an increase of 53% compared to the...
MarketBeat·2d ago
News Placeholder
Rezolve AI (NASDAQ:RZLV) Shares Gap Up - Here's What Happened
Rezolve AI (NASDAQ:RZLV) Shares Gap Up - Still a Buy...
MarketBeat·2d ago
News Placeholder
Why Is Rezolve AI Stock Gaining Monday?
Rezolve AI (RZLV) shares jump after smashing FY revenue estimates with $46.8M. Explore the 543% H2 growth and new $360M guidance here.read more...
Benzinga·2d ago
News Placeholder
Why Rezolve AI Stock Is Rising Today
Key PointsRezolve AI outpaced Wall Street's revenue estimate in 2025...
Nasdaq News: Markets·2d ago
News Placeholder
RZLV Stock Sees Massive Rally Today – Investors Cheer Company’s 7X Revenue Surge Projection For 2026
The company reported $46.8 million in annual revenue, beating estimates, with second-half growth surging 543% over the first half.
Stocktwits·2d ago
News Placeholder
Rezolve AI Q4 Earnings Call Highlights
Rezolve AI (NASDAQ:RZLV) executives used the company's second-half and full-year 2025 earnings call to highlight a sharp ramp in recurring revenue, an expanded customer base, and raised financial...
MarketBeat·2d ago
News Placeholder
The Boom Enters New Phase
The artificial intelligence boom is entering a new phase, one defined less by infrastructure and more by real-world application. Nowhere is that shift more visible than in biotech, where data, diagnostics, and drug discovery are converging into a high-stakes innovation race. Recent developments across public markets show both the promise and the volatility of this transition, as capital flows toward platforms capable of turning complex biological data into actionable outcomes. $KBLB, $BFRG, $RZLV, $ELAB, $EEIQ, $ITRM
24-7 Market News·2d ago
News Placeholder
RZLV Jumps 13% Ahead Of Half Year Report – Analysts Expect Huge Upside Potential This Year
All of the six analysts covering the stock have a ‘Buy’ or higher rating, and, on average, forecast 370% gains in the stock over 12 months.
Stocktwits·2d ago
<
1
2
...
>

Latest RZLV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.